Daily pill helps shed pounds in major obesity trial
NCT ID NCT05035095
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study tested a daily oral tablet of semaglutide (50 mg) to help people with overweight or obesity lose weight. 667 adults took either the active drug or a placebo for 68 weeks, along with lifestyle advice. The main goals were to measure the percentage of weight lost and how many participants lost at least 5% of their body weight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accellacare
Wilmington, North Carolina, 28401, United States
-
Capital Clin Res Ctr,LLC
Olympia, Washington, 98502, United States
-
Centre Hospitalier Universitaire de Bordeaux-Hopital Haut Leveque-2
Pessac, 33600, France
-
Centre Hospitalier Universitaire de Nantes-Hopital Nord Laennec
Saint-Herblain, 44800, France
-
Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil-2
Toulouse, 31054, France
-
Centre de Recherche Clinique Portes Du Sud
Vénissieux, 69200, France
-
Centrum Medyczne Pratia Gdynia
Gdynia, Pomeranian Voivodeship, 81-338, Poland
-
Centrum Terapii Wspolczesnej J.M. Jasnorzewska S.K.A.
Lodz, 90-338, Poland
-
Centrum Zdrowia Metabolicznego Paweł Bogdański
Poznan, Wielkopolskie Voivodeship, 60-589, Poland
-
Chiba University Hospital_Diabetes, Metabolism and Endocrinology
Chiba-shi, Chiba, 260-8677, Japan
-
Clinical Trial Res Assoc,Inc
Plantation, Florida, 33324, United States
-
Diabetes Zentrum Wandsbek Berufsausuebungsgemeinschaft GbR
Hamburg, 22041, Germany
-
Dr. Milek medikum
Hohenmölsen, 06679, Germany
-
East West Med Res Inst
Honolulu, Hawaii, 96814, United States
-
Endocrinological Dispensary of Department of healthcare ser.
Moscow, 119034, Russia
-
FSBI 'I.I. Dedov National Medical Research Center of Endocrinology' of the MH of Russia
Moscow, 117292, Russia
-
Federal Bureau for Medical and Social Expertise
Moscow, 127486, Russia
-
Fondation Hôtel-Dieu
Le Creusot, 71200, France
-
G.A. Research Associates Ltd.
Moncton, New Brunswick, E1G 1A7, Canada
-
Gabinet Leczenia Otylosci i Chorob Dietozaleznych
Bialystok, Podlaskie Voivodeship, 15-281, Poland
-
Gentofte Hospital - Center for Klinisk Metabolisk Forskning
Hellerup, 2900, Denmark
-
Groupe Sos Sante-Hopital Le Creusot-Hotel Dieu-2
Le Creusot, 71200, France
-
Higashi-shinjuku clinic
Tokyo, 169-0072, Japan
-
Hvidovre Hospital Endokrinologisk forsknings afsnit 159
Hvidovre, 2650, Denmark
-
InnoDiab Forschung GmbH
Essen, 45136, Germany
-
Joint Stock Company "Medical technologies"
Yekaterinburg, 620075, Russia
-
Joint Stock Company "Polyclinic Complex"
Saint Petersburg, 190013, Russia
-
LLC "Clinic of new technologies in Medicine"
Dzerzhinskiy, 140091, Russia
-
Leningrad Regional Clinical Hospital
Saint Petersburg, 194291, Russia
-
Les Hopitaux de Chartres-Hopital Louis Pasteur
Le Coudray, 28630, France
-
MZM Praxis Drs. Erlinger
Stuttgart, 70378, Germany
-
Midwest Inst For Clin Res
Indianapolis, Indiana, 46260, United States
-
NZOZ Przychodnia Specjalistyczna Medica
Lublin, Lubelski, 20-538, Poland
-
Nova Scotia Health Authority
Halifax, Nova Scotia, B3H 1V7, Canada
-
Obesity Research Unit
Helsinki, 00014, Finland
-
Ocean West Research Clinic
Surrey, British Columbia, V3Z 2N6, Canada
-
Praxis Dr. med. M. Esser
Essen, 45219, Germany
-
Praxis Dr. med. Wenzl-Bauer
Rehlingen-Siersburg, 66780, Germany
-
Premier Clinical Trial Research Network (PCTRN)
Hamilton, Ontario, L8M 1K7, Canada
-
RED-Institut für medizinische Forschung und Fortbildung GmbH
Oldenburg in Holstein, 23758, Germany
-
Rochester Clinical Research, Inc.
Rochester, New York, 14609, United States
-
Seinäjoen keskussairaala
Seinäjoki, 60220, Finland
-
Selma Medical Associates
Winchester, Virginia, 22601-3834, United States
-
Sjællands Universitetshospital, Køge - Medicinsk Afdeling
Køge, Region Sjælland, 4600, Denmark
-
Slagelse Sygehus Ambulatorium for hjertesygdomme
Slagelse, 4200, Denmark
-
StudyCor
Jyväskylä, 40620, Finland
-
Suidoubashi Medical Clinic_Internal Medicine
Chiyoda-ku, Tokyo, 101-0065, Japan
-
The Chappel Group Research
Kissimmee, Florida, 34744, United States
-
The University of Penn Center
Philadelphia, Pennsylvania, 19104-3317, United States
-
Tumen State Medical University
Tyumen, Russia, 625023, Russia
-
Univ of Alabama Birmingham
Birmingham, Alabama, 35233, United States
-
Velocity Clin Res Los Angeles
Los Angeles, California, 90017, United States
-
Velocity Clinical Res-Dallas
Dallas, Texas, 75230, United States
-
Washington Cntr Weight Mgmt
Arlington, Virginia, 22206, United States
-
Wharton Medical Clinic Clinical Trials (Hamilton)
Hamilton, Ontario, L8L 5G8, Canada
-
Zentrum für klinische Studien Allgäu Oberschwaben
Wangen, 88239, Germany
Conditions
Explore the condition pages connected to this study.